Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.

Show other versions (1)

Bibliographic Details
Main Authors:	Balermpas, P, Michel, Y, Wagenblast, J, Seitz, O, Weiss, C, Rödel, F, Rödel, C, Fokas, E
Format:	Journal article
Language:	English
Published:	2014

Similar Items

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
by: Balermpas, P, et al.
Published: (2014)

Erratum: Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
by: Balermpas, P, et al.
Published: (2014)

Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.
by: Balermpas, P, et al.
Published: (2014)

Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences.
by: Balermpas, P, et al.
Published: (2014)

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer
by: Daniel Martin, et al.
Published: (2017-09-01)

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
by: Daniel Martin, et al.
Published: (2019-11-01)

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
by: Balermpas, P, et al.
Published: (2016)

Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
by: Rödel, F, et al.
Published: (2015)

Human papilloma virus load and PD-1/PD-L1, CD8+ and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
by: Panagiotis Balermpas, et al.
Published: (2017-03-01)

Complete response after chemoradiotherapy for rectal cancer: what is the reasonable approach?
by: Rödel Claus, et al.
Published: (2017-12-01)

Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma
by: Daniel Martin, et al.
Published: (2020-08-01)

Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial
by: Jens von der Grün, et al.
Published: (2022-03-01)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon?
by: Fokas, E, et al.
Published: (2015)

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
by: D. Martin, et al.
Published: (2024-04-01)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon?
by: Fokas, E, et al.
Published: (2015)

Breathing-Swallowing discoordination after definitive chemoradiotherapy for head and neck cancers is associated with aspiration pneumonia.
by: Takuya Yoshida, et al.
Published: (2024-01-01)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
by: Yeona Cho, et al.
Published: (2018-10-01)

Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study
by: Alev Altay-Langguth, et al.
Published: (2021-05-01)

C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
by: Alina Frey, et al.
Published: (2022-03-01)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
by: Warren, S, et al.
Published: (2016)

Radiomic Analysis of Tumour Heterogeneity Using MRI in Head and Neck Cancer Following Chemoradiotherapy: A Feasibility Study
by: Amrita Guha, et al.
Published: (2022-02-01)

ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
by: Maximilian Fleischmann, et al.
Published: (2022-05-01)

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy
by: Fraunholz Ingeborg, et al.
Published: (2012-06-01)

Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma
by: Asier Rabasco Meneghetti, et al.
Published: (2021-01-01)

Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Head and Neck Squamous Cell Carcinoma
by: Qiaoshi Xu, et al.
Published: (2017-02-01)

Weight loss in post-chemoradiotherapy head and neck cancer patients
by: Abu Zaid, Zalina, et al.
Published: (2022)

Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy
by: Gunjesh Kumar Singh, et al.
Published: (2017-03-01)

Squamous Cell Carcinoma of the Head and Neck: Dramatic Response to Chemoradiotherapy
by: Seyed Basir Hashemi, et al.
Published: (2010-01-01)

Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density
by: Xu Y, et al.
Published: (2021-11-01)

Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy
by: Max Fleischmann, et al.
Published: (2019-08-01)

Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma: A Focus on Tumor-Infiltrating Lymphocytes
by: Marzieh Norouzian, et al.
Published: (2019-08-01)

Gender characteristics of head's and neck's tumours
by: V F Antoniv, et al.
Published: (2011-09-01)

Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer
by: Tycho de Bakker, et al.
Published: (2024-12-01)

A preliminary Study on the Effect of Head and Neck Chemoradiotherapy on Systematic Immunity
by: Weiqiang Huang, et al.
Published: (2019-10-01)

Cytotoxic response of tumor-infiltrating lymphocytes of head and neck cancer slice cultures under mitochondrial dysfunction
by: Maria do Carmo Greier, et al.
Published: (2024-03-01)

RARE MALIGNANT SKIN TUMOURS OF THE HEAD AND NECK
by: Oroz Aleksandar, et al.
Published: (2018-12-01)

Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
by: Glaire, MA, et al.
Published: (2019)

Correlation of PDL-1 Expression with Tumour Budding and Tumour Infiltrating Lymphocytes in Colorectal Cancers
by: Tejasvita Singh, et al.
Published: (2023-07-01)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
by: Ioannis M. Koukourakis, et al.
Published: (2022-06-01)

Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
by: Yikan Sun, et al.
Published: (2024-09-01)